Correlation Between Pluri and Corvus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Pluri and Corvus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pluri and Corvus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pluri Inc and Corvus Pharmaceuticals, you can compare the effects of market volatilities on Pluri and Corvus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pluri with a short position of Corvus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pluri and Corvus Pharmaceuticals.
Diversification Opportunities for Pluri and Corvus Pharmaceuticals
-0.57 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Pluri and Corvus is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Pluri Inc and Corvus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Corvus Pharmaceuticals and Pluri is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pluri Inc are associated (or correlated) with Corvus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Corvus Pharmaceuticals has no effect on the direction of Pluri i.e., Pluri and Corvus Pharmaceuticals go up and down completely randomly.
Pair Corralation between Pluri and Corvus Pharmaceuticals
Given the investment horizon of 90 days Pluri Inc is expected to under-perform the Corvus Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Pluri Inc is 1.08 times less risky than Corvus Pharmaceuticals. The stock trades about -0.01 of its potential returns per unit of risk. The Corvus Pharmaceuticals is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest 224.00 in Corvus Pharmaceuticals on August 27, 2024 and sell it today you would earn a total of 671.00 from holding Corvus Pharmaceuticals or generate 299.55% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pluri Inc vs. Corvus Pharmaceuticals
Performance |
| Timeline |
| Pluri Inc |
| Corvus Pharmaceuticals |
Pluri and Corvus Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pluri and Corvus Pharmaceuticals
The main advantage of trading using opposite Pluri and Corvus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pluri position performs unexpectedly, Corvus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corvus Pharmaceuticals will offset losses from the drop in Corvus Pharmaceuticals' long position.The idea behind Pluri Inc and Corvus Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Corvus Pharmaceuticals vs. Mereo BioPharma Group | Corvus Pharmaceuticals vs. Terns Pharmaceuticals | Corvus Pharmaceuticals vs. PDS Biotechnology Corp | Corvus Pharmaceuticals vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |